336 related articles for article (PubMed ID: 11533208)
1. Molecular basis for the relative substrate specificity of human immunodeficiency virus type 1 and feline immunodeficiency virus proteases.
Beck ZQ; Lin YC; Elder JH
J Virol; 2001 Oct; 75(19):9458-69. PubMed ID: 11533208
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for distinctions between substrate and inhibitor specificities for feline immunodeficiency virus and human immunodeficiency virus proteases.
Lin YC; Beck Z; Morris GM; Olson AJ; Elder JH
J Virol; 2003 Jun; 77(12):6589-600. PubMed ID: 12767979
[TBL] [Abstract][Full Text] [Related]
4. Alteration of substrate and inhibitor specificity of feline immunodeficiency virus protease.
Lin YC; Beck Z; Lee T; Le VD; Morris GM; Olson AJ; Wong CH; Elder JH
J Virol; 2000 May; 74(10):4710-20. PubMed ID: 10775609
[TBL] [Abstract][Full Text] [Related]
5. Altered gag polyprotein cleavage specificity of feline immunodeficiency virus/human immunodeficiency virus mutant proteases as demonstrated in a cell-based expression system.
Lin YC; Brik A; de Parseval A; Tam K; Torbett BE; Wong CH; Elder JH
J Virol; 2006 Aug; 80(16):7832-43. PubMed ID: 16873240
[TBL] [Abstract][Full Text] [Related]
6. Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease.
Li M; Morris GM; Lee T; Laco GS; Wong CH; Olson AJ; Elder JH; Wlodawer A; Gustchina A
Proteins; 2000 Jan; 38(1):29-40. PubMed ID: 10651036
[TBL] [Abstract][Full Text] [Related]
7. Generation of infectious feline immunodeficiency virus (FIV) encoding FIV/human immunodeficiency virus chimeric protease.
Lin YC; Torbett BE; Elder JH
J Virol; 2010 Jul; 84(13):6799-809. PubMed ID: 20410281
[TBL] [Abstract][Full Text] [Related]
8. Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis.
Schnölzer M; Rackwitz HR; Gustchina A; Laco GS; Wlodawer A; Elder JH; Kent SB
Virology; 1996 Oct; 224(1):268-75. PubMed ID: 8862421
[TBL] [Abstract][Full Text] [Related]
9. Kinetic and modeling studies of subsites S4-S3' of Moloney murine leukemia virus protease.
Menéndez-Arias L; Weber IT; Soss J; Harrison RW; Gotte D; Oroszlan S
J Biol Chem; 1994 Jun; 269(24):16795-801. PubMed ID: 8207003
[TBL] [Abstract][Full Text] [Related]
10. Specificity and inhibition of proteases from human immunodeficiency viruses 1 and 2.
Tomasselli AG; Hui JO; Sawyer TK; Staples DJ; Bannow C; Reardon IM; Howe WJ; DeCamp DL; Craik CS; Heinrikson RL
J Biol Chem; 1990 Aug; 265(24):14675-83. PubMed ID: 2201691
[TBL] [Abstract][Full Text] [Related]
11. Mutational analysis of the substrate binding pockets of the Rous sarcoma virus and human immunodeficiency virus-1 proteases.
Cameron CE; Ridky TW; Shulenin S; Leis J; Weber IT; Copeland T; Wlodawer A; Burstein H; Bizub-Bender D; Skalka AM
J Biol Chem; 1994 Apr; 269(15):11170-7. PubMed ID: 8157644
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Protease Uses Bi-Specific S2/S2' Subsites to Optimize Cleavage of Two Classes of Target Sites.
Potempa M; Lee SK; Kurt Yilmaz N; Nalivaika EA; Rogers A; Spielvogel E; Carter CW; Schiffer CA; Swanstrom R
J Mol Biol; 2018 Dec; 430(24):5182-5195. PubMed ID: 30414407
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3.
Heaslet H; Lin YC; Tam K; Torbett BE; Elder JH; Stout CD
Retrovirology; 2007 Jan; 4():1. PubMed ID: 17212810
[TBL] [Abstract][Full Text] [Related]
14. A continuous fluorometric assay for the feline immunodeficiency virus protease.
Fitzgerald MC; Laco GS; Elder JH; Kent SB
Anal Biochem; 1997 Dec; 254(2):226-30. PubMed ID: 9417781
[TBL] [Abstract][Full Text] [Related]
15. Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases.
Menéndez-Arias L; Weber IT; Oroszlan S
J Biol Chem; 1995 Dec; 270(49):29162-8. PubMed ID: 7493942
[TBL] [Abstract][Full Text] [Related]
16. Analysis of substrate interactions of the Rous sarcoma virus wild type and mutant proteases and human immunodeficiency virus-1 protease using a set of systematically altered peptide substrates.
Grinde B; Cameron CE; Leis J; Weber IT; Wlodawer A; Burstein H; Skalka AM
J Biol Chem; 1992 May; 267(14):9491-8. PubMed ID: 1315756
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases.
Laco GS; Fitzgerald MC; Morris GM; Olson AJ; Kent SB; Elder JH
J Virol; 1997 Jul; 71(7):5505-11. PubMed ID: 9188624
[TBL] [Abstract][Full Text] [Related]
18. Amino acid preferences for a critical substrate binding subsite of retroviral proteases in type 1 cleavage sites.
Bagossi P; Sperka T; Fehér A; Kádas J; Zahuczky G; Miklóssy G; Boross P; Tözsér J
J Virol; 2005 Apr; 79(7):4213-8. PubMed ID: 15767422
[TBL] [Abstract][Full Text] [Related]
19. Amino acid preferences of retroviral proteases for amino-terminal positions in a type 1 cleavage site.
Eizert H; Bander P; Bagossi P; Sperka T; Miklóssy G; Boross P; Weber IT; Tözsér J
J Virol; 2008 Oct; 82(20):10111-7. PubMed ID: 18701588
[TBL] [Abstract][Full Text] [Related]
20. Structure of an inhibitor complex of the proteinase from feline immunodeficiency virus.
Wlodawer A; Gustchina A; Reshetnikova L; Lubkowski J; Zdanov A; Hui KY; Angleton EL; Farmerie WG; Goodenow MM; Bhatt D
Nat Struct Biol; 1995 Jun; 2(6):480-8. PubMed ID: 7664111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
